Litigation Details for Celltrion Healthcare Co., Ltd. v. Janssen Biotech, Inc. (D. Mass. 2014)
✉ Email this page to a colleague
Celltrion Healthcare Co., Ltd. v. Janssen Biotech, Inc. (D. Mass. 2014)
| Docket | ⤷ Sign Up | Date Filed | 2014-03-31 |
| Court | District Court, D. Massachusetts | Date Terminated | 2014-10-24 |
| Cause | 28:1338 Patent Infringement | Assigned To | Mark Lawrence Wolf |
| Jury Demand | None | Referred To | |
| Patents | 6,071,970; 7,994,364; 8,163,798; 8,309,060; 8,536,130; 8,629,179 | ||
| Link to Docket | External link to docket | ||
Details for Celltrion Healthcare Co., Ltd. v. Janssen Biotech, Inc. (D. Mass. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2014-07-07 | 25 | Exhibit 4 | related to the ‘593 and ‘364 patents and United States Patent No. 6,071,970. In response to those notices…invalidate three patents owned by Kennedy (the Feldman patents). The Feldman patents are licensed to JBI…United States Reissue Patent No. 39,593 (the '593 patent), United States Patent No. 7,994,364 (the …x27;364 patent) and, as to Actavis only, United States Patent No. 8,309,060 (the '060 patent). The …Contact Lenses infringe their U.S. Patent No. 5,712,327 (the Chang patent). Rembrandt is seeking monetary | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
